StockData
Inovio Pharmaceuticals, Inc. logo

Inovio Pharmaceuticals, Inc. (INO) stock

INONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$1.63+0.23 (+16.43%)

Close on Nov 17, 2026Market cap $168.54MP/E –Yield –

Inovio Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Inovio Pharmaceuticals's price to sales ratio was 478.9× on Jan 30, 2026, against 231.6× a year earlier. Over the last 5 years it ranged from 10.0× to 478.9×, with a median of 244.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jan 30, 2026478.9×+5.7
2025Oct 31, 2025473.2×+238.9
2024Dec 31, 2024234.4×+73.3
2023Dec 29, 2023161.1×+125.6
2022Dec 30, 202235.5×−125.6
2021Dec 31, 2021161.1×−135.5
2020Apr 30, 2020296.6×+245.0
2019Dec 31, 201951.6×+41.3
2018Dec 31, 201810.3×+1.4
2017Dec 29, 20178.9×−6.8
2016Dec 30, 201615.7×+2.6
2015Dec 31, 201513.1×−43.9
2014Dec 31, 201457.0×+10.2
2013Dec 31, 201346.8×+32.3
2012Dec 31, 201214.5×+5.9
2011Jul 29, 20118.5×–

More Inovio Pharmaceuticals figures

See a number that looks wrong?